152 related articles for article (PubMed ID: 7040662)
1. Use of adenine nucleotide derivatives to assess the potential of exo-active-site-directed reagents as species- or isozyme-specific enzyme inactivators. 5. Interactions of adenosine 5'-triphosphate derivatives with rat pyruvate kinases, Escherichia coli thymidine kinase, and yeast and rat hexokinases.
Hampton A; Patel AD; Chawla RR; Kappler F; Hai TT
J Med Chem; 1982 Apr; 25(4):386-92. PubMed ID: 7040662
[TBL] [Abstract][Full Text] [Related]
2. Use of adenine nucleotide derivatives to assess the potential of exo-active-site-directed reagents as species- or isozyme-specific enzyme inactivators. 4. Interactions of adenosine 5'-triphosphate derivatives with adenylate kinases from Escherichia coli and rat tissues.
Hampton A; Picker D; Nealy KA; Maeda M
J Med Chem; 1982 Apr; 25(4):382-6. PubMed ID: 6279845
[TBL] [Abstract][Full Text] [Related]
3. Use of adenine nucleotide derivatives to assess the potential of exo-active-site-directed reagents as species- or isozyme-specific enzyme inactivators. 3. Synthesis of adenosine 5'-triphosphate derivatives with N6- or 8-substituents bearing iodoacetyl groups.
Hampton A; Patel AD; Maeda M; Hai TT; Chang CD; Kang JB; Kappler F; Abo M; Preston RK
J Med Chem; 1982 Apr; 25(4):373-81. PubMed ID: 6279844
[TBL] [Abstract][Full Text] [Related]
4. Species- or isozyme-specific enzyme inhibitors. 9. Selective effects in inhibitions of rat pyruvate kinase isozymes by adenosine 5'-diphosphate derivatives.
Hai TT; Abo M; Hampton A
J Med Chem; 1982 Oct; 25(10):1184-8. PubMed ID: 7143354
[TBL] [Abstract][Full Text] [Related]
5. Species- or isozyme-specific enzyme inhibitors. 6. Synthesis and evaluation of two-substrate condensation products as inhibitors of hexokinases and thymidine kinases.
Hampton A; Hai TT; Kappler F; Chawla RR
J Med Chem; 1982 Jul; 25(7):801-5. PubMed ID: 7108896
[TBL] [Abstract][Full Text] [Related]
6. Inactivation of rabbit, pig, and carp adenylate kinases by N6-o- and p-fluorobenzoyladenosine 5'-triphosphates.
Hampton A; Slotin LA
Biochemistry; 1975 Dec; 14(25):5438-44. PubMed ID: 172123
[TBL] [Abstract][Full Text] [Related]
7. Use of adenine nucleotide derivatives to assess the potential of exo-active-site-directed reagents as species- or isozyme-specific enzyme inactivators. 2. Isozyme-specific inactivation of a mammalian enzyme and its significance in the possible design of fetal isozyme targeted antineoplastic agents.
Hampton A; Kappler F; Maeda M; Patel AD
J Med Chem; 1978 Nov; 21(11):1137-40. PubMed ID: 722719
[No Abstract] [Full Text] [Related]
8. Evidence for species-specific substrate-site-directed inactivation of rabbit adenylate kinase by N6-(6-iodoacetamido-n-hexyl)adenosine 5'-triphosphate.
Hampton A; Slotin LA; Chawla RR
J Med Chem; 1976 Nov; 19(11):1279-83. PubMed ID: 187748
[TBL] [Abstract][Full Text] [Related]
9. Design of substrate-site-directed inhibitors of adenylate kinase and hexokinase. Effect of substrate substituents on affinity on affinity for the adenine nucleotide sites.
Hampton A; Slotin LA; Kappler F; Sasaki T; Perini F
J Med Chem; 1976 Dec; 19(12):1371-7. PubMed ID: 187750
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and biochemical characterization of the new sulfhydryl-reactive ATP analogue 8-thiocyano-ATP. Its interaction with Na,K-ATPase and kinases.
Scheiner-Bobis G; Mertens W; Willeke M; Schoner W
Biochemistry; 1992 Feb; 31(7):2107-13. PubMed ID: 1311206
[TBL] [Abstract][Full Text] [Related]
11. Species- or isozyme-specific enzyme inhibitors. 5. Differential effects of thymidine substituents on affinity for rat thymidine kinase isozymes.
Hampton A; Chawla RR; Kappler F
J Med Chem; 1982 Jun; 25(6):644-9. PubMed ID: 7097717
[TBL] [Abstract][Full Text] [Related]
12. Isozyme-specific enzyme inhibitors. 10. Adenosine 5'-triphosphate derivatives as substrates or inhibitors of methionine adenosyltransferases of rat normal and hepatoma tissues.
Kappler F; Hai TT; Hampton A
J Med Chem; 1986 Mar; 29(3):318-22. PubMed ID: 3950912
[TBL] [Abstract][Full Text] [Related]
13. Functional organization of mammalian hexokinases: characterization of the rat type III isozyme and its chimeric forms, constructed with the N- and C-terminal halves of the type I and type II isozymes.
Tsai HJ; Wilson JE
Arch Biochem Biophys; 1997 Feb; 338(2):183-92. PubMed ID: 9028870
[TBL] [Abstract][Full Text] [Related]
14. Functional organization of mammalian hexokinases: both N- and C-terminal halves of the rat type II isozyme possess catalytic sites.
Tsai HJ; Wilson JE
Arch Biochem Biophys; 1996 May; 329(1):17-23. PubMed ID: 8619630
[TBL] [Abstract][Full Text] [Related]
15. Reaction of pyruvate kinase with the new nucleotide affinity labels 8-[(4-bromo-2,3-dioxobutyl)thio]adenosine 5'-diphosphate and 5'-triphosphate.
DeCamp DL; Lim S; Colman RF
Biochemistry; 1988 Oct; 27(20):7651-8. PubMed ID: 3207694
[TBL] [Abstract][Full Text] [Related]
16. Functional organization and evolution of mammalian hexokinases: mutations that caused the loss of catalytic activity in N-terminal halves of type I and type III isozymes.
Tsai HJ
Arch Biochem Biophys; 1999 Sep; 369(1):149-56. PubMed ID: 10462451
[TBL] [Abstract][Full Text] [Related]
17. The effect of the nitrosourea analog of thymidine, 3'-[3-(2-chloroethyl)-3-nitrosoureido]-3'-deoxythymidine, on Escherichia coli thymidine kinase.
Chen MS; Lin TS; Prusoff WH
Biochim Biophys Acta; 1980 Nov; 616(1):35-40. PubMed ID: 7002216
[TBL] [Abstract][Full Text] [Related]
18. Species- or isozyme-specific enzyme inhibitors. 7. Selective effects in inhibitions of rat adenylate kinase isozymes by adenosine 5'-phosphate derivatives.
Hai TT; Picker D; Abo M; Hampton A
J Med Chem; 1982 Jul; 25(7):806-12. PubMed ID: 6286970
[TBL] [Abstract][Full Text] [Related]
19. Approaches to isozyme-specific inhibitors. 16. A novel methyl-C5' covalent adduct of L-ethionine and beta,gamma-imido-ATP as a potent multisubstrate inhibitor of rat methionine adenosyltransferases.
Vrudhula VM; Kappler F; Afshar C; Ginell SL; Lessinger L; Hampton A
J Med Chem; 1989 Apr; 32(4):885-90. PubMed ID: 2784835
[TBL] [Abstract][Full Text] [Related]
20. How do MgATP analogues differentially modify high-affinity and low-affinity ATP binding sites of Na+/K(+)-ATPase?
Serpersu EH; Bunk S; Schoner W
Eur J Biochem; 1990 Jul; 191(2):397-404. PubMed ID: 2166662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
